​

Lexeo Therapeutics Ownership | Who Owns Lexeo Therapeutics?

OverviewForecastFinancialsChart

Lexeo Therapeutics Ownership Summary

Lexeo Therapeutics is owned by 89.28% institutional investors, 0.49% insiders, and 10.23% retail investors. Rothschild investment is the largest institutional shareholder, holding 0% of LXEO shares.

LXEO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLexeo Therapeutics89.28%0.49%10.23%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rothschild investment---
Gamma investing---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rothschild investment---
Gamma investing---

Top Buyers

HolderShares% AssetsChange
Rothschild investment---20.00
Gamma investing---245.00

Top Sellers

HolderShares% AssetsChange
Gamma investing---245.00
Rothschild investment---20.00

Sold Out

HolderChange
Rothschild investment-20.00
Gamma investing-245.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20248932.84%29,519,159-0.73%891.10%5913.46%1137.50%
Sep 30, 20246717.54%29,735,11411.93%891.39%5233.33%8-38.46%
Jun 30, 2024575.56%26,566,62614.91%801.18%39-15.22%13160.00%
Mar 31, 20245474.19%23,119,89342.94%822.24%4648.39%5-
Dec 31, 202331-16,174,480-60-31---

Recent Insider Transactions

DateNameRoleActivityValue
Feb 19, 2025Townsend Richard Nolan Chief Executive OfficerSell$19.09K
Feb 19, 2025See Tai Sandi Chief Development OfficerSell$6.56K
Feb 19, 2025Adler Eric Chief Medical OfficerSell$10.41K
Feb 19, 2025Robertson Jenny Chief Legal OfficerSell$9.27K
Dec 10, 2024Townsend Richard Nolan Chief Executive OfficerSell$20.49K

Insider Transactions Trends

DateBuySell
2025 Q1-4
2024 Q413
2024 Q3-1
2023 Q42-

LXEO Ownership FAQ

Who Owns Lexeo Therapeutics?

Lexeo Therapeutics shareholders are primarily institutional investors at 89.28%, followed by 0.49% insiders and 10.23% retail investors. The average institutional ownership in Lexeo Therapeutics's industry, Biotech Stocks , is 68.48%, which Lexeo Therapeutics exceeds.

Does Blackrock own Lexeo Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Lexeo Therapeutics.

Who is Lexeo Therapeutics’s biggest shareholder by percentage of total assets invested?

Rothschild investment is Lexeo Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Lexeo Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools